Studies have highlighted MGAM as a critical target for traditional Chinese herbal formulas such as Mahuang Fuzi Xixin Decoction (MFXD) in treating lung cancer, particularly in LUAD, where it is a key mutated gene51, 52 In non‐small cell lung cancer (NSCLC), nearly 18% of patients with specific EGFR mutations also presented MGAM–BRAF fusions, underscoring the gene's importance in this context.53 Here, BRAF is linked to lung carcinoma.